CNPY2 and atherosclerosis: CNPY2 aggravated the process of atherosclerosis in ApoE-/- mice in vivo and induced endothelial cell injury in vitro; the latter was markedly attenuated when the cells were treated with the PERK inhibitor GSK2606414 [73].